The Nigeria Academy of Pharmacy (NAPHARM) has emphasised the critical role of pharmaceutical innovation in driving national development, stressing that investment in research, local manufacturing, and digital health is essential for building a resilient pharmaceutical value chain.
This was highlighted at the recent academy’s 2025 Annual General Meeting and Investiture Ceremony, which brought together experts in the pharmaceutical industry to discuss the significance of innovation in improving healthcare outcomes.
The Group Managing Director of FBN Holdings Plc, Mr. Wale Oyedeji, noted that pharmaceutical innovation is not just about developing new drugs, but also about creating an ecosystem that supports knowledge, entrepreneurship, and collaboration across public and private sectors.